Newsfeeds - Spark Newswire

1 minute read

Gracell Biotechnologies’ Abstract On GC012F Accepted For Presentation At 2022 ASCO Annual Meeting

Today, 11:55 PM

Gracell Biotechnologies Inc. ((", Gracell", or the ", Company", , NASDAQ:GRCL), a global clinical-stage biopharmaceutical company dedicated to developing highly efficacious and affordable cell

GRCL

3 minute read

35 Stocks Moving In Monday’s Mid-Day Session

By Lisa Levin

Today, 11:55 PM

Gainers Aterian, Inc. (NASDAQ: ATER) shares jumped 43.5% to $3.3457. Aterian said Cynthia Williams has joined the Company's Board of Directors.

AERC

7 minute read

Benzinga’s Top Ratings Upgrades, Downgrades For April 4, 2022

By Benzinga Insights

Today, 11:55 PM

Upgrades

ALHC

1 minute read

BTIG Initiates Coverage On Gracell Biotechnologies with Buy Rating, Announces Price Target of $18

By Benzinga Newsdesk

Today, 11:55 PM

BTIG analyst Justin Zelin initiates coverage on Gracell Biotechnologies (NASDAQ:GRCL) with a Buy rating and announces Price Target of $18.

GRCL

3 minute read

12 Health Care Stocks Moving In Thursday’s Intraday Session

By Benzinga Insights

Today, 11:55 PM

APTX

2 minute read

12 Health Care Stocks Moving In Monday’s Intraday Session

By Benzinga Insights

Today, 11:55 PM

AIH

3 minute read

50 Stocks Moving In Monday’s Mid-Day Session

By Lisa Levin

Today, 11:55 PM

Gainers Volt Information Sciences, Inc. (NYSE: VOLT) shares jumped 95.2% to $5.89 after the company announced it would be acquired for $6 per share.

ACMR

1 minute read

Gracell Biotechnologies: Q4 Earnings Insights

By Benzinga Insights

Today, 11:55 PM

Gracell Biotechnologies (NASDAQ:GRCL) reported its Q4 earnings results on Monday, March 14, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

GRCL